Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response

被引:18
|
作者
Keefe, Matthew D. [1 ]
Soderholm, Haille E. [1 ]
Shih, Hung-Yu [1 ]
Stevenson, Tamara J. [1 ]
Glaittli, Kathryn A. [1 ]
Bowles, D. Miranda [1 ]
Scholl, Erika [1 ]
Colby, Samuel [2 ]
Merchant, Samer [2 ]
Hsu, Edward W. [2 ]
Bonkowsky, Joshua L. [1 ,3 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
[3] Primary Childrens Med Ctr, Brain & Spine Ctr, Salt Lake City, UT 84113 USA
来源
ELIFE | 2020年 / 9卷
基金
美国国家卫生研究院;
关键词
ONSET EIF2B-RELATED DISORDERS; NATURAL-HISTORY; TRANSLATION; LEUKOENCEPHALOPATHY; OLIGODENDROCYTES; PHENOTYPE; GENOTYPE;
D O I
10.7554/eLife.56319
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vanishing white matter disease (VWM) is a severe leukodystrophy of the central nervous system caused by mutations in subunits of the eukaryotic initiation factor 2B complex (eIF2B). Current models only partially recapitulate key disease features, and pathophysiology is poorly understood. Through development and validation of zebrafish (Danio rerio) models of VWM, we demonstrate that zebrafish eif2b mutants phenocopy VWM, including impaired somatic growth, early lethality, effects on myelination, loss of oligodendrocyte precursor cells, increased apoptosis in the CNS, and impaired motor swimming behavior. Expression of human EIF2B2 in the zebrafish eif2b2 mutant rescues lethality and CNS apoptosis, demonstrating conservation of function between zebrafish and human. In the mutants, intron 12 retention leads to expression of a truncated eif2b5 transcript. Expression of the truncated eif2b5 in wild-type larva impairs motor behavior and activates the ISR, suggesting that a feed-forward mechanism in VWM is a significant component of disease pathophysiology.
引用
收藏
页数:27
相关论文
共 50 条
  • [11] EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy
    Jörg Dietrich
    Michelle Lacagnina
    David Gass
    Eric Richfield
    Margot Mayer-Pröschel
    Mark Noble
    Carlos Torres
    Christoph Pröschel
    Nature Medicine, 2005, 11 : 277 - 283
  • [12] Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5
    Matsukawa, Takashi
    Wang, Xuemin
    Liu, Rui
    Wortham, Noel C.
    Onuki, Yuko
    Kubota, Akatsuki
    Hida, Ayumi
    Kowa, Hisatomo
    Fukuda, Yoko
    Ishiura, Hiroyuki
    Mitsui, Jun
    Takahashi, Yuji
    Aoki, Shigeki
    Takizawa, Shunya
    Shimizu, Jun
    Goto, Jun
    Proud, Christopher G.
    Tsuji, Shoji
    NEUROGENETICS, 2011, 12 (03) : 259 - 261
  • [13] Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5
    Takashi Matsukawa
    Xuemin Wang
    Rui Liu
    Noel C. Wortham
    Yuko Onuki
    Akatsuki Kubota
    Ayumi Hida
    Hisatomo Kowa
    Yoko Fukuda
    Hiroyuki Ishiura
    Jun Mitsui
    Yuji Takahashi
    Shigeki Aoki
    Shunya Takizawa
    Jun Shimizu
    Jun Goto
    Christopher G. Proud
    Shoji Tsuji
    neurogenetics, 2011, 12 : 259 - 261
  • [14] In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice
    Bock, Desiree
    Revers, Ilma M.
    Bomhof, Anastasia S. J.
    Hillen, Anne E. J.
    Boeijink, Claire
    Kissling, Lucas
    Egli, Sabina
    Moreno-Mateos, Miguel A.
    van der Knaap, Marjo S.
    van Til, Niek P.
    Schwank, Gerald
    MOLECULAR THERAPY, 2024, 32 (05) : 1328 - 1343
  • [15] A novel missense variant in EIF2B5 identified in a consanguineous Iranian family with vanishing white matter disease and a brief review of the literature
    Parisa Nourmohammadi
    Mostafa Asadollahi
    Arezou Karamzade
    Yeganeh Eshaghkhani
    Meisam Babaei
    Zahra Golchehre
    Seyedeh Roksana Taheri
    Sepideh Hasani
    Mahdieh Taghizadeh
    Mohammad Keramatipour
    Journal of Genetics, 102
  • [16] A novel missense variant in EIF2B5 identified in a consanguineous Iranian family with vanishing white matter disease and a brief review of the literature
    Nourmohammadi, Parisa
    Asadollahi, Mostafa
    Karamzade, Arezou
    Eshaghkhani, Yeganeh
    Babaei, Meisam
    Golchehre, Zahra
    Taheri, Seyedeh Roksana
    Hasani, Sepideh
    Taghizadeh, Mahdieh
    Keramatipour, Mohammad
    JOURNAL OF GENETICS, 2023, 102 (02)
  • [17] Leukoencephalopathy with vanishing white matter: Clinicopathological characteristics of a rare adult-onset case with a homozygous EIF2B5 mutation
    Seike, Naohiko
    Shimizu, Hiroshi
    Tanaka, Koh
    Ikeuchi, Takeshi
    Tanaka, Masaharu
    Takahashi, Hitoshi
    Kakita, Akiyoshi
    BRAIN PATHOLOGY, 2019, 29 : 97 - 97
  • [18] Infantile Onset Vanishing White Matter Disease Associated with a Novel EIF2B5 Variant, Remarkably Long Life Span, Severe Epilepsy, and Hypopituitarism
    Woody, April L.
    Hsieh, David T.
    McIver, Harkirtin K.
    Thomas, Linda P.
    Rohena, Luis
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (04) : 826 - 830
  • [19] An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report
    Trevisan, Lucia
    Grazzini, Matteo
    Cianflone, Annalia
    Accogli, Andrea
    Finocchi, Cinzia
    Capello, Elisabetta
    Saitta, Laura
    Grandis, Marina
    Roccatagliata, Luca
    Mandich, Paola
    NEUROCASE, 2021, 27 (06) : 452 - 456
  • [20] Characterisation of EIF2B bodies in vanishing white matter disease
    Hodgson, R.
    Allen, K. E.
    Campbell, S.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 219 - 220